Tokyo, Japan

Tomotaka Shinya


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tomotaka Shinya: Innovator in Allergy Treatment

Introduction

Tomotaka Shinya is a prominent inventor based in Tokyo, Japan. He is known for his significant contributions to the field of immunology, particularly in developing treatments for cedar pollinosis. His innovative work has the potential to improve the quality of life for many individuals suffering from this allergy.

Latest Patents

Tomotaka Shinya holds a patent for a protein that exhibits immunogenicity related to cedar pollen. The patent, titled "Protein having immunogenicity of cedar pollen, polynucleotide encoding the protein, and use thereof," aims to provide a solution for treating patients with cedar pollinosis. The invention includes a protein with a specific amino acid sequence, a polynucleotide encoding this protein, and various intended uses, including its incorporation as a food product. This breakthrough could benefit a wide range of patients, offering a novel approach to allergy management. He has 1 patent to his name.

Career Highlights

Throughout his career, Tomotaka Shinya has worked with notable organizations, including Nippon Paper Industries Co., Ltd. and the National Institute of Agrobiological Sciences. His experience in these institutions has allowed him to develop and refine his innovative ideas, contributing to advancements in allergy treatment.

Collaborations

Tomotaka Shinya has collaborated with esteemed colleagues such as Fumio Takaiwa and Hidenori Takagi. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of immunology.

Conclusion

Tomotaka Shinya's work in developing a protein for cedar pollinosis treatment showcases his dedication to innovation in allergy management. His contributions have the potential to significantly impact the lives of those affected by this condition.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…